LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Henry Schein Inc

Chiusa

SettoreSettore sanitario

70.41 0.09

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

70.15

Massimo

71.26

Metriche Chiave

By Trading Economics

Entrata

17M

113M

Vendite

-23M

3.2B

P/E

Media del settore

21.67

51.198

EPS

1.15

Margine di Profitto

3.567

Dipendenti

25,000

EBITDA

16M

253M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+4.84% upside

Dividendi

By Dow Jones

Utili prossimi

5 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.2B

8.7B

Apertura precedente

70.32

Chiusura precedente

70.41

Notizie sul Sentiment di mercato

By Acuity

44%

56%

151 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Henry Schein Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 gen 2025, 13:28 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal

16 mag 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Henry Schein: William K. Daniel Joins Board

16 mag 2025, 20:10 UTC

Acquisizioni, Fusioni, Takeovers

Henry Schein: Strategic Investment by KKR Completed

29 gen 2025, 14:04 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

KKR Builds Stake in Medical-Supply Company -- 2nd Update

29 gen 2025, 12:54 UTC

Acquisizioni, Fusioni, Takeovers

KKR Builds Stake in Medical-Supply Company -- Update

29 gen 2025, 12:07 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Sees 2025 Adjusted Ebitda Up Mid-Single Digits >HSIC

29 gen 2025, 12:07 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Sees 2025 Revenue Up Low- to Mid-Single Digits >HSIC

29 gen 2025, 12:06 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein: KKR Buying $250 Million in New Shares Based on Market Price >HSIC

29 gen 2025, 12:06 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Sees 4Q Rev $3.2B >HSIC

29 gen 2025, 12:03 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein: KKR Representatives Max Lin, William Daniel to Join Board >HSIC

29 gen 2025, 12:03 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein: KKR Will Have Ability to Boost Stake to 14.9% via Open Market Purchases >HSIC

29 gen 2025, 12:02 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Names Robert Hombach an Independent Director >HSIC

29 gen 2025, 12:02 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Increases Share-Repurchase Program Authorization by $500 Million >HSIC

29 gen 2025, 12:02 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Sees 2025 Adjusted EPS Up Low- to Mid-Single Digits >HSIC

29 gen 2025, 12:01 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein Sees 4Q Adj EPS $1.19 >HSIC

29 gen 2025, 12:00 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein, KKR to Collaborate Range of Value Creation Opportunities >HSIC

29 gen 2025, 12:00 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Henry Schein: KKR to Become 12% Common Shareholder >HSIC

29 gen 2025, 10:30 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats -- WSJ

29 gen 2025, 10:30 UTC

Acquisizioni, Fusioni, Takeovers

Henry Schein Has Already Been an Activist Target -- WSJ

29 gen 2025, 10:30 UTC

Acquisizioni, Fusioni, Takeovers

Private-Equity Firm KKR to Work to Improve Operations at Medical and Dental Supplier, Sources Say -- WSJ

29 gen 2025, 10:30 UTC

Acquisizioni, Fusioni, Takeovers

KKR Has Taken a Big Stake in Henry Schein, Will Get Two Board Seats, Sources Say -- WSJ

Confronto tra pari

Modifica del prezzo

Henry Schein Inc Previsione

Obiettivo di Prezzo

By TipRanks

4.84% in crescita

Previsioni per 12 mesi

Media 73.88 USD  4.84%

Alto 86 USD

Basso 55 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Henry Schein Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

9 ratings

3

Acquista

5

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

66.23 / N/ASupporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

151 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.